Combination of Rituximab and Cyclosporine in the Treatment of Primary Membranous Nephropathy

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2026
High-grade proteinuria is one of the key determinants of adverse renal prognosis in patients with primary membranous nephropathy (PMN).The main purpose of this study is to determine whether Rituximab combined with Cyclosporine is superior to Rituximab monotherapy in inducing remission of proteinuria in patients with PMN.
Epistemonikos ID: af139610427952f3c9f68b00852d107d9fba691c
First added on: Oct 07, 2026